Bill Maughan
Stock Analyst at Canaccord Genuity
(n/a)
# 4,564
Out of 4,944 analysts
17
Total ratings
11.11%
Success rate
-36.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bill Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| YMAB Y-mAbs Therapeutics | Downgrades: Hold | $26 → $8.6 | $8.51 | +1.06% | 3 | Aug 6, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $190 | $143.62 | +32.29% | 1 | Jul 1, 2025 | |
| CRSP CRISPR Therapeutics AG | Downgrades: Hold | $45 | $56.60 | -20.49% | 1 | Jun 27, 2025 | |
| NKTX Nkarta | Maintains: Buy | $16 → $15 | $1.96 | +665.31% | 2 | May 10, 2024 | |
| FATE Fate Therapeutics | Maintains: Buy | $11 → $9 | $0.94 | +861.23% | 1 | May 10, 2024 | |
| IMCR Immunocore Holdings | Maintains: Hold | $63 → $67 | $31.87 | +110.23% | 3 | May 9, 2024 | |
| MRNA Moderna | Maintains: Hold | $91 → $106 | $25.66 | +313.09% | 3 | May 3, 2024 | |
| IPSC Century Therapeutics | Maintains: Buy | $22 → $24 | $0.52 | +4,533.20% | 1 | Mar 15, 2024 | |
| BCYC Bicycle Therapeutics | Reiterates: Buy | $60 | $7.22 | +731.02% | 1 | Feb 21, 2024 | |
| MRUS Merus | Initiates: Buy | $45 | $63.76 | -29.42% | 1 | Nov 2, 2023 |
Y-mAbs Therapeutics
Aug 6, 2025
Downgrades: Hold
Price Target: $26 → $8.6
Current: $8.51
Upside: +1.06%
Krystal Biotech
Jul 1, 2025
Initiates: Buy
Price Target: $190
Current: $143.62
Upside: +32.29%
CRISPR Therapeutics AG
Jun 27, 2025
Downgrades: Hold
Price Target: $45
Current: $56.60
Upside: -20.49%
Nkarta
May 10, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $1.96
Upside: +665.31%
Fate Therapeutics
May 10, 2024
Maintains: Buy
Price Target: $11 → $9
Current: $0.94
Upside: +861.23%
Immunocore Holdings
May 9, 2024
Maintains: Hold
Price Target: $63 → $67
Current: $31.87
Upside: +110.23%
Moderna
May 3, 2024
Maintains: Hold
Price Target: $91 → $106
Current: $25.66
Upside: +313.09%
Century Therapeutics
Mar 15, 2024
Maintains: Buy
Price Target: $22 → $24
Current: $0.52
Upside: +4,533.20%
Bicycle Therapeutics
Feb 21, 2024
Reiterates: Buy
Price Target: $60
Current: $7.22
Upside: +731.02%
Merus
Nov 2, 2023
Initiates: Buy
Price Target: $45
Current: $63.76
Upside: -29.42%